Skip to main content

iSpecimen Inc.

ISPC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001558569

No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding iSpecimen Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of ISPC: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders1113+2
Shares299.2K334.4K+35.2K (+11.8%)
Value$69.1K$103.1K+$34.0K (+49.2%)

New holders (7)

Institutions that held iSpecimen Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ISPC in Q2 2024
InstitutionSharesValue% of portfolio
HRT Financial LP45,935$14.0K0.00%
Virtu Financial LLC42,087$13.0K0.00%
Citadel Advisors LLC25,500$7.88K0.00%
Jane Street Group, LLC19,888$6.14K0.00%
StoneX Group Inc.14,742$4.55K0.00%
Bank of America Corp43$130.00%
Sachetta, LLC22$60.00%

Sold out (5)

Institutions that held iSpecimen Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of ISPC in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Millennium Management LLC44,057$10.2K
Schonfeld Strategic Advisors LLC15,200$3.53K
Renaissance Technologies LLC10,000$2.00K
Tower Research Capital LLC (TRC)3,186$739
Wells Fargo & Company42$10